Vylor (NYSE:VYLR) Stock Gets Price Target Reduction from UBS Group

Vylor (NYSE:VYLR – Get Free Report) had its price objective lowered by analysts at UBS Group from $89.00 to $87.00 in a report released on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group‘s price objective would suggest a potential upside of 20.11% from the stock’s current price.

A number of other equities analysts have also recently commented on VYLR. KeyCorp initiated coverage on shares of Vylor in a research report on Wednesday, October 7th. They set a “sector weight” rating and a $78.00 price objective for the company. The Goldman Sachs Group began coverage on shares of Vylor in a research report on Thursday, October 8th. They issued a “buy” rating and a $87.00 price objective on the stock. Royal Bank Of Canada started coverage on shares of Vylor in a research note on Friday, October 2nd. They set an “outperform” rating and a $85.00 target price for the company. Mizuho began coverage on shares of Vylor in a research note on Monday, October 5th. They set an “outperform” rating and a $84.00 target price for the company. Finally, Weiss Ratings raised shares of Vylor from a “sell (d+)” rating to a “hold (c+)” rating in a report on Friday, October 16th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Vylor has an average rating of “Moderate Buy” and a consensus price target of $82.50.

Read Our Latest Stock Report on Vylor

Vylor Trading Up 0.5%

Shares of NYSE VYLR traded up $0.38 during midday trading on Friday, hitting $72.44. 949,693 shares of the company’s stock were exchanged, compared to its average volume of 4,727,629. Vylor has a 12 month low of $65.00 and a 12 month high of $77.39.

Vylor (NYSE:VYLR – Get Free Report) last posted its earnings results on Thursday, November 12th. The company reported ($0.42) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.52) by $0.10. The business had revenue of $938.00 million for the quarter, compared to analyst estimates of $846.03 million. Vylor’s revenue was down .6% on a year-over-year basis. On average, equities analysts anticipate that Vylor will post 2.33 earnings per share for the current year.

Vylor declared that its Board of Directors has approved a share repurchase plan on Thursday, October 22nd that permits the company to buy back $3 billion in shares. This repurchase authorization permits the company to buy up to 6.3% of its stock through open market purchases. Share repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

About Vylor

(Get Free Report)

Vylor Inc. is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc. is based in JOHNSTON, Iowa.

See Also

Analyst Recommendations for Vylor (NYSE:VYLR)

Receive News & Ratings for Vylor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vylor and related companies with MarketBeat.com's FREE daily email newsletter.